New Key Statistics Module, Z-Score and F-Score
OTCPK:AQSZF Key Ratios
Market Cap $ M | 0.96 |
Enterprise Value $ M | 4.89 |
P/E(ttm) | -- |
PE Ratio without NRI | -- |
Forward PE Ratio | -- |
Price/Book | -- |
Price/Sales | 5.00 |
Price/Free Cash Flow | -- |
Price/Owner Earnings | -- |
Payout Ratio % | -- |
Revenue (TTM) $ M | -- |
EPS (TTM) $ | -0.01 |
Beneish M-Score | -9.56 |
10-y EBITDA Growth Rate % | 22.70 |
5-y EBITDA Growth Rate % | 7.00 |
y-y EBITDA Growth Rate % | -- |
EV-to-EBIT | -3.30 |
EV-to-EBITDA | -3.48 |
PEG | -- |
Shares Outstanding M | 132.63 |
Net Margin (%) | -1,864.96 |
Operating Margin % | -1,750.43 |
Pre-tax Margin (%) | -1,864.96 |
Quick Ratio | 0.07 |
Current Ratio | 0.09 |
ROA % (ttm) | -195.40 |
ROE % (ttm) | -- |
ROIC % (ttm) | -40.89 |
Dividend Yield % | -- |
Altman Z-Score | -56.28 |
AQSZF Number of Guru Trades
AQSZF Volume of Guru Trades
Gurus Latest Trades with OTCPK:AQSZF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
OTCPK:AQSZF is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Aequus Pharmaceuticals Inc Insider Transactions
No Available Data
News about OTCPK:AQSZF
Total 0- 1